CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000450956.63883.15
Contributors

CONTRIBUTORS

Free Access
Article Outline
Collapse Box

Author Information

aRelationship Disclosure

bUnlabeled Use of Products/Investigational Use Disclosure

Joseph E. Safdieh, MD, FAAN, Guest Editor

Vice Chairman for Education; Associate Professor of Neurology, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, New York

aDr Safdieh receives research support from Accera, Inc, and serves on the speakers bureau for Supernus Pharmaceuticals, Inc.

bDr Safdieh reports no disclosure.

Vera Bril, BSc, MD, FRCP(c)

Professor, University of Toronto; Chief of Neurology, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada

aDr Bril has received grant support and personal compensation for consultancy work from Dainippon Sumitomo Pharma Co, Ltd; Eisai, Inc; Eli Lilly and Company; Pfizer Inc; and Grifols, Canada, Ltd. Dr Bril has also received grant support from Cebix Incorporated, CSL Behring, and Novartis Corporation, as well as unrestricted educational fellow support from Grifols, Canada, Ltd.

bDr Bril discusses the unlabeled use of gabapentin, amitriptyline, morphine, and oxycodone for the treatment of neuromuscular complications of diabetes mellitus.

John C. M. Brust, MD, FAAN

Professor of Neurology, Columbia University College of Physicians and Surgeons, New York, New York

aDr Brust serves as an editor for Current Neurology and Neuroscience Reports and has received compensation for reviewing medical records related to a hospital malpractice suit.

bDr Brust reports no disclosure.

Jonathan M. Goldstein, MD

Director of Perioperative Neurology; Associate Attending Neurologist; Neurology, Neuromuscular Diseases, and Electromyography, Hospital for Special Surgery, Department of Neurology, New York, New York

aDr Goldstein has served on advisory panels for CSL-Behring and Grifols and as a speaker for Athena Diagnostics, Inc.

bDr Goldstein discusses the unlabeled use of cyclophosphamide, rituximab, methotrexate, azathioprine, mycophenolate mofetil, and cyclosporine.

Sara E. Hocker, MD

Assistant Professor of Neurology, Mayo Clinic, Rochester, Minnesota

a,bDr Hocker reports no disclosures.

Anna Hohler, MD, FAAN

Associate Professor of Neurology, Boston University School of Medicine, Boston, Massachusetts

aDr Hohler has received personal compensation for activities with Teva Neuroscience and travel expenses were paid by the AAN for attending meetings of BrainPAC and the Quality and Safety Subcommittee.

bDr Hohler reports no disclosure.

Makoto Ishii, MD, PhD

Instructor in Neuroscience, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York

aDr Ishii has received an unrestricted research grant from the Leon Levy Foundation.

bDr Ishii reports no disclosure.

Steven Karceski, MD

Assistant Professor of Neurology, Weill Cornell Medical College, New York, New York

aDr Karceski serves as an associate editor of Neurology and as a speaker for Cyberonics, Inc.

bDr Karceski reports no disclosure.

Neeraj Kumar, MD

Professor of Neurology, Mayo Clinic, Rochester, Minnesota

a,bDr Kumar reports no disclosures.

Jessica D. Lee, MD, FAAN

Neurology Director, University of Kentucky HealthCare Stroke Program; Associate Professor of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky

aDr Lee has received grant support from the NIH and her travel expenses were paid by the AAN for attending meetings of the Quality and Safety Subcommittee.

bDr Lee reports no disclosure.

James M. Noble, MD

Assistant Professor of Neurology, Columbia University, New York, New York

aDr Noble receives grants from the National Institutes of Aging and the National Institute of Dental and Craniofacial Research.

bDr Nobel reports no disclosure.

Amy Premetz, MS, RHIA

Manager of Ambulatory Coding and Education, Rush University Medical Center, Chicago, Illinois

a,bMs Premetz reports no disclosures.

Barney J. Stern, MD, FAAN

Professor, Department of Neurology, University of Maryland, Baltimore, Maryland

aDr Stern has served as an expert witness, as editor of The Neurologist, and serves on the Data and Safety Monitoring Board and as a medical safety monitor at the National Institute of Neurological Disorders and Stroke. Dr Stern receives research support from the National Institute of Neurological Disorders and Stroke and Remedy Pharmaceuticals.

bDr Stern reports no disclosure.

Jinny O. Tavee, MD

Assistant Professor, Lerner College of Medicine Center; Neuromuscular Fellowship Program Director, Cleveland Clinic, Neuromuscular Center, Cleveland, Ohio

aDr Tavee is involved in a clinical trial funded by Araim Pharmaceuticals, Inc, evaluating the use of ARA290 in patients with small fiber neuropathy related to sarcoidosis.

bDr Tavee reports no disclosure.

Benjamin David Tolchin, MD, MS

Neurology Resident, New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York

a,bDr Tolchin reports no disclosures.

Allison L. Weathers, MD

Associate Chief Medical Information Officer; Associate Professor, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois

aDr Weathers has received honoraria for grand rounds and lectures given for the Los Angeles Neurological Society, Wake Forest Neurology Department, and the North Carolina Neurological Society. Dr Weathers also received travel reimbursement for participation on AAN committees.

bDr Weathers reports no disclosure.

Louis H. Weimer, MD, FAAN

Professor of Neurology, Columbia University, New York, New York

a,bDr Weimer reports no disclosure.

Halina White, MD

Assistant Professor of Neurology, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, New York

aDr White holds $25,000 of stock in Tethys Bioscience, Inc.

bDr White reports no dislosures.

Eelco F. M. Wijdicks, MD, PhD, FAAN

Professor of Neurology; Chair, Division of Critical Care Neurology, Mayo Clinic, Rochester, Minnesota

a,bDr Wijdicks reports no disclosures.

Joshua Z. Willey, MD, MS

Assistant Professor of Neurology, Columbia University, New York, New York

aDr Willey has received a K-23 grant from the NIH and an honorarium from the American College of Physicians for the Medical Knowledge Self-Assessment Program.

bDr Willey reports no disclosure.

Back to Top | Article Outline

SELF-ASSESSMENT AND CME TEST WRITERS

Eduardo E. Benarroch, MD, FAAN

Professor of Neurology, Mayo Clinic, Rochester, Minnesota

a,bDr Benarroch reports no disclosures.

D. Joanne Lynn, MD, FAAN

Associate Dean for Student Life and Clinical Professor of Neurology, The Ohio State University College of Medicine, Columbus, Ohio

aDr Lynn receives honorarium for her work as a question writer from Continuum: Lifelong Learning in Neurology and receives book royalties from Lippincott Williams & Wilkins. Dr Lynn holds stock in Bristol-Myers Squibb Company, Corning Incorporated,General Electric, and Varian Medical Systems, Inc.

bDr Lynn reports no disclosure.

Copyright © 2014 by the American Academy of Neurology.

Login